首页 > 市场调查报告书 > 製药

再生医学细胞疗法

市场调查报告书

商品编码

1547892

全球自然杀手细胞治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Natural Killer Cells Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球自然杀手细胞治疗市场的需求预计将从2023年的30.6亿美元达到2032年近125.9亿美元的市场规模，2024-2032年研究期间的复合年增长率为17.02%。

自然杀手细胞疗法是医学界快速成长的市场。它们是一组能够快速回应病理挑战的颗粒淋巴细胞。它们还负责在我们的体内产生免疫调节细胞因子，这是消除任何病理挑战所必需的。它们是人体先天免疫系统所需的重要助推器。此外，它们还帮助身体做好针对病原体快速反应的准备。

市场动态

更多的资源被用于开发先进疗法，包括自然杀手细胞，因为它们对于预防和治疗传染病以及消除感染者体内的癌细胞非常有用。自然杀手细胞治疗市场的主要驱动力是癌症和肝病治疗市场，该技术在这些市场中已广泛应用。冠状病毒的爆发使人们更加了解可以增强免疫系统的疗法，这对市场起到了重大推动作用。市场面临的主要限制是高成本和低特异性。此外，这些培养物的生存机会很低，并且需要一些时间才能生长，这对市场来说是一个挑战。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球自然杀手细胞治疗市场的每个细分市场进行了包容性评估。自然杀手细胞治疗产业的成长和趋势为这项研究提供了整体方法。

市场区隔

自然杀手细胞治疗市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

透过治疗分析

NK 细胞定向抗体
NK 细胞疗法

按应用分析

免疫增生性疾病
胃肠道疾病
癌症
其他应用

透过最终用户分析

医院
研究中心和研究所
其他最终用户

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲自然杀手细胞治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。自然杀手细胞治疗市场的主要参与者包括 NKT Therapeutics Inc.、Nkarta Therapeutics Inc.、Nantkwest Inc.、Innate Pharma SA、Glycostem Therapeutics BV、Fortress Biotech、Fate Therapeutics、Celgene Corporation、Affimed NV 和 Ziopharm Oncology Inc.。的。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：自然杀手细胞治疗公司的竞争格局

自然杀手细胞治疗市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
NKT Therapeutics Inc.

公司概况
公司收入
产品
最新动态

Nkarta Therapeutics Inc.

公司概况
公司收入
产品
最新动态

Nantkwest Inc.

公司概况
公司收入
产品
最新动态

Innate Pharma SA

公司概况
公司收入
产品
最新动态

Glycostem Therapeutics BV

公司概况
公司收入
产品
最新动态

Fortress Biotech

公司概况
公司收入
产品
最新动态

Fate Therapeutics

公司概况
公司收入
产品
最新动态

Celgene Corporation

公司概况
公司收入
产品
最新动态

Affimed NV And Ziopharm Oncology Inc.

公司概况
公司收入
产品
最新动态

其他的
- 公司概况
- 公司收入
- 产品
- 最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11212583

The global demand for Natural Killer Cells Therapeutics Market is presumed to reach the market size of nearly USD 12.59 Billion by 2032 from USD 3.06 Billion in 2023 with a CAGR of 17.02% under the study period 2024-2032.

Natural killer cell therapeutics is a rapidly rising market in the medical world. They are a group of granular lymphocytes that can quickly respond to a pathological challenge. They are also responsible for producing immunoregulatory cytokines in our body, which are necessary for eliminating any kind of pathological challenge. They are the vital booster needed for the innate immune system of the human body. Also, they prepare the body for a quick response against a pathogen.

MARKET DYNAMICS

More resources are being used behind the development of advanced therapies, including natural killer cells, as they are extremely useful for preventing and curing infectious diseases and also for eliminating cancer cells from an infected person. The major driver for the natural killer cells therapeutics market is the market for cancer and liver disease treatment, where this technique is widely used. The coronavirus outbreak has caused people to be more aware of the therapies that can strengthen their immune systems, and it has acted as a major boost for the market. The major restraint being faced by the market is in the form of high costs and low specificity. Also, the cultures have low chances of survival and take some time to grow, which is a challenge for the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Natural Killer Cells Therapeutics. The growth and trends of Natural Killer Cells Therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Natural Killer Cells Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapeutics Analysis

NK Cell Directed Antibodies
NK Cell Therapies

By Application Analysis

Immunoproliferative Disorders
Gastrointestinal Diseases
Cancer
Other Applications

By End User Analysis

Hospitals
Research Centers & Institutes
Other End Users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Natural Killer Cells Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Natural Killer Cells Therapeutics market include NKT Therapeutics Inc., Nkarta Therapeutics Inc., Nantkwest Inc., Innate Pharma S.A., Glycostem Therapeutics BV, Fortress Biotech, Fate Therapeutics, Celgene Corporation, Affimed N.V. And Ziopharm Oncology Inc., Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. NATURAL KILLER CELLS THERAPEUTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Therapeutics Analysis
- 3.7.2 Market Attractiveness Analysis By Application Analysis
- 3.7.3 Market Attractiveness Analysis By End User Analysis
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY THERAPEUTICS ANALYSIS

5.1. Overview By Therapeutics Analysis
5.2. Historical and Forecast Data
5.3. Analysis By Therapeutics Analysis
5.4. NK Cell Directed Antibodies Historic and Forecast Sales By Regions
5.5. NK Cell Therapies Historic and Forecast Sales By Regions

6. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY APPLICATION ANALYSIS

6.1. Overview By Application Analysis
6.2. Historical and Forecast Data
6.3. Analysis By Application Analysis
6.4. Immunoproliferative Disorders Historic and Forecast Sales By Regions
6.5. Gastrointestinal Diseases Historic and Forecast Sales By Regions
6.6. Cancer Historic and Forecast Sales By Regions
6.7. Other Applications Historic and Forecast Sales By Regions

7. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY END USER ANALYSIS

7.1. Overview By End User Analysis
7.2. Historical and Forecast Data
7.3. Analysis By End User Analysis
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Research Centers & Institutes Historic and Forecast Sales By Regions
7.6. Other End Users Historic and Forecast Sales By Regions

8. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE NATURAL KILLER CELLS THERAPEUTICS COMPANIES

9.1. Natural Killer Cells Therapeutics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF NATURAL KILLER CELLS THERAPEUTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. NKT Therapeutics Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Nkarta Therapeutics Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Nantkwest Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Innate Pharma S.A.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Glycostem Therapeutics BV
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Fortress Biotech
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Fate Therapeutics
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Celgene Corporation
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Affimed N.V. And Ziopharm Oncology Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Others
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments